Kringle Pharma, Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

17

Website

www.kringle-pharma.com

Country

Japan

Exchange

Tokyo

Kringle Pharma provides research and develops therapeutic agents for the treatment of intractable diseases in Japan. The company develops HGF products for the treatment of acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scar, and acute kidney injury. Kringle Pharma, Inc. was incorporated in 2001 and is based in Kita, Japan.

Key Stats

52-Week Range

¥287.00¥601.00

Beta0.41

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-130.14

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.